Furosemide 40mg tablets

Ülke: Birleşik Krallık

Dil: İngilizce

Kaynak: MHRA (Medicines & Healthcare Products Regulatory Agency)

Aktif bileşen:

Furosemide

Mevcut itibaren:

Ennogen Pharma Ltd

ATC kodu:

C03CA01

INN (International Adı):

Furosemide

Doz:

40mg

Farmasötik formu:

Oral tablet

Uygulama yolu:

Oral

Sınıf:

No Controlled Drug Status

Reçete türü:

Valid as a prescribable product

Ürün özeti:

BNF: 02020200; GTIN: 05060313370653

Bilgilendirme broşürü

Furosemide 20mg Tablets
Furosemide 40mg Tablets
[FUROSEMIDE]
PACKAGE LEAFLET: INFORMATION FOR THE USER
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START
TAKING THIS MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
!
Keep this leaflet. You may need to read it
again.
!
If you have further questions, ask your doctor
or pharmacist or nurse.
!
This medicine has been prescribed for you
only. Do not pass it on to others. It may harm
them, even if their signs of illness are the same
as yours.
!
If you get any side effects, talk to your doctor,
pharmacist or nurse. This includes any possible
side effects not listed in this leaflet. See section
4.
WHAT IS IN THIS LEAFLET:
1.
WHAT FUROSEMIDE TABLETS ARE AND WHAT THEY
ARE USED FOR
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE
FUROSEMIDE TABLETS
3.
HOW TO TAKE FUROSEMIDE TABLETS
4.
POSSIBLE SIDE EFFECTS
5.
HOW TO STORE FUROSEMIDE TABLETS
6.
CONTENTS OF THE PACK AND OTHER INFORMATION
1. WHAT FUROSEMIDE TABLETS ARE AND
WHAT THEY ARE USED FOR
Furosemide Tablets are one of a group of
medicines called diuretics (water tablets).
Your doctor has prescribed Furosemide Tablets to
treat a condition called oedema where there is too
much water in your body. This could be due to
problems with your heart, kidneys, liver, blood
vessels or high blood pressure. Furosemide helps
your kidneys to get rid of extra water that is not
needed in your body.
2. WHAT YOU NEED TO KNOW BEFORE YOU
TAKE FUROSEMIDE TABLETS
DO NOT TAKE FUROSEMIDE TABLETS IF YOU:
!
Are allergic to furosemide or any of the other
ingredients of this medicine (listed in section 6).
Signs of an allergic reaction include: a rash,
swallowing or breathing problems, swelling of
the lips, face, throat or tongue
!
Are allergic to amiloride, sulfonamides or
sulphonamide derivatives, such as sulfadiazine
or cotrimoxazole
!
Have a low blood volume or are dehydrated
(with or without accompanying low blood
pressure)
!
Have too little potassium or sodium in your
blood (shown in blood test)
!
Have severe liver problems (cirrhosis)
!
Ha

Ürün özellikleri

1
NAME OF THE MEDICINAL PRODUCT
Furosemide Tablets 40mg
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains furosemide BP 40mg.
Excipient(s) with known effect
Lactose
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Tablet
White round biconvex tablet, approximately 8.0 mm in diameter, with
‘F40’ embossed on one
side and plain on the reverse.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Furosemide is a diuretic for the management of oedema of cardiac,
renal or hepatic origin,
pulmonary oedema, toxaemia of pregnancy, and mild or moderate
hypertension.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Initial dosage 1 tablet daily. This is then adjusted to the minimum
effective dose which can
range from ½ tablet (20mg) on alternate days to 2 tablets (80mg) or
more in resistant oedema.
_Children _
1mg to 3mg per kilogram body weight daily up to a maximum of 40mg/day.
_Elderly: _
Furosemide is eliminated more slowly in the elderly. Dosage should be
adjusted according to
the observed clinical response.
Method of administration: Oral.
4.3 CONTRAINDICATIONS
•
Hypersensitivity to the active substance(s) or to any of the
excipients listed in section 6.1.
•
Hypersensitivity to amiloride, sulphonamides or sulphonamide
derivatives.
•
Hypovolaemia or dehydration (with or without accompanying hypotension)
(see section
4.4).
•
Severe hypokalaemia, severe hyponatraemia (see section 4.4).
•
Comatose or pre-comatose states associated with hepatic cirrhosis (see
section 4.4).
•
Anuria or renal failure with anuria not responding to furosemide,
renal failure as a result
of poisoning by nephrotoxic or hepatotoxic agents or renal failure
associated with hepatic
coma.
•
Impaired renal function with a creatinine clearance below 30ml/min per
1.73m
2
body
surface area (see section 4.4).
•
Addison’s disease (see section 4.4).
•
Digitalis intoxication (see section 4.5).
•
Concomitant potassium supplements or potassium sparing diuretics (see
section 4.5).
•
Porphyria.
•
Breast-fee